Most studies have investigated NRGN genetic polymorphisms in adults with schizophrenia [68–70] and in cerebrospinal fluid (CSF) in Alzheimer’s disease [71,72], relating NRGN to learning and memory impairment [73–75]. This evidence concerns the gene NRGN and early-onset autosomal dominant Alzheimer disease.